Product image of Norditropin Flexpro (Somatropin) supplied by GNH India

Norditropin Flexpro

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin FlexPro, is a recombinant human growth hormone presented as a 5 mg per pen solution for injection (pen) for subcutaneous use. It treats growth hormone deficiency and related growth disorders in children and adults.

GNH India supplies Norditropin FlexPro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Novo Nordisk Pharma Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin FlexPro (somatropin) is used to address conditions related to growth hormone deficiency and associated growth disorders.

  • Growth hormone deficiency in children: promotes linear growth and improves height velocity.
  • Turner syndrome: supports growth and increases final adult height.
  • Adult growth hormone deficiency: restores normal metabolic function and body composition.
  • Prader‑Willi syndrome: enhances growth and improves body composition.
  • Chronic renal insufficiency associated growth failure: aids in achieving normal growth patterns.
  • Idiopathic short stature: stimulates growth when other causes have been excluded.

How It Works

  • Somatropin binds to specific growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling pathway. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and other downstream mediators, leading to increased protein synthesis, cell proliferation, and linear bone growth, while also influencing metabolism of carbohydrates, lipids, and minerals.

Side Effects

Common Side Effects

  • Injection site pain: mild discomfort at the injection site.
  • Headache: transient and usually mild.
  • Joint stiffness: occasional stiffness in large joints.
  • Swelling of extremities: peripheral edema, especially in hands and feet.

Serious or Rare Side Effects

  • Intracranial hypertension: signs include headache, visual changes, and nausea.
  • Hyperglycemia: elevated blood glucose requiring monitoring.
  • Slipped capital femoral epiphysis: hip pain and limited motion in adolescents.
  • Severe allergic reaction (anaphylaxis): rash, difficulty breathing, or swelling of the face.

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Monitor blood glucose: assess for hyperglycemia, especially in diabetic patients.
  • Assess for intracranial hypertension: watch for persistent headaches or visual disturbances.
  • Evaluate for musculoskeletal disorders: screen for scoliosis or hip joint abnormalities.
  • Screen for malignancy: avoid use in patients with active cancer.
  • Adjust dose in renal impairment: consider reduced dosing in severe renal insufficiency.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin may interact with several medicines. Review the following:

Major Interactions (Avoid)

  • Glucocorticoids: may antagonize growth hormone effects and reduce efficacy.
  • Estrogen therapy: can increase IGF‑1 levels, potentially leading to excess growth.

Moderate Interactions (Monitor Closely)

  • Oral hypoglycemic agents: may require adjustment of glucose‑lowering therapy.
  • Thyroid hormone replacement: monitor thyroid function tests regularly.
  • Diuretics: may affect fluid balance and exacerbate edema.

Frequently Asked Questions

Norditropin FlexPro contains somatropin, a recombinant human growth hormone indicated for treating growth hormone deficiency in children and adults, Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency‑related growth failure, idiopathic short stature, and certain genetic conditions that cause short stature.

Somatropin binds to growth hormone receptors, activating intracellular signaling that increases production of insulin‑like growth factor‑1 (IGF‑1). IGF‑1 promotes bone growth, protein synthesis, and metabolic effects, leading to increased height in children and improved body composition in adults.

The dose of Norditropin FlexPro is individualized. A qualified prescriber determines the appropriate amount based on the patient’s age, weight, indication, and response to therapy, and provides specific administration instructions.

Safety of somatropin in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the prescribing physician.

To order, submit an enquiry on the Norditropin FlexPro product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and necessary import documentation.

Norditropin FlexPro delivers somatropin in a pre‑filled pen that offers precise dosing and ease of subcutaneous injection. Compared with vial‑based formulations, the pen reduces preparation steps and dosing errors, while providing comparable efficacy and safety profiles to other recombinant human growth hormones.

The product must be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the pen in its original packaging until use, and discard any solution that appears discolored or contains particles.

Norditropin FlexPro is administered subcutaneously using the pre‑filled pen. The prescriber selects the appropriate dose on the pen dial, cleans the injection site with an alcohol swab, inserts the needle, and injects the dose at a 90‑degree angle. Disposal follows local sharps‑waste regulations.

Serious risks include intracranial hypertension, hyperglycemia, slipped capital femoral epiphysis, and severe allergic reactions such as anaphylaxis. Patients should be monitored regularly for symptoms like persistent headache, visual changes, elevated blood glucose, hip pain, or signs of an allergic response.

Norditropin FlexPro is contraindicated in individuals with known hypersensitivity to somatropin or any excipients, active malignancy, or those who have experienced severe adverse reactions to growth hormone therapy. It should also be avoided in patients with uncontrolled diabetes without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT